The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Leukemia Propagating Cells Rebuild an Evolving Niche in Response to Therapy
Open accessAbstract
Residence of cancer-propagating cells (CPCs) within preferential microenvironmental niches has a major part in evading therapy. However, the nature of niches involved and the mechanisms protecting CPCs remain largely unknown. We addressed these issues in mouse transplantation models of acute lymphoblastic leukemia (ALL). When the engrafted leukemic cells substantially damaged adjacent microenvironment in the bone marrow (BM), after chemotherapy small foci of CPCs were retained, surrounded by sheaths of supporting cells that comprise a protective niche. We investigated patients' BM biopsies and found evidence of a similar process in patients receiving induction therapy. The efficacy of chemotherapy was enhanced by interfering with the niche formation or function. We therefore identified a therapy-induced niche that protects CPCs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These altered cells are difficult to eliminate by conventional antitumoral agents because drugs do not reach the bone marrow at the required concentration, and because the stem cell niche (a physical and functional entity that supports the self-renewal and differentiation of stem cells) changes/adapts after chemotherapy, protecting altered cells97.”
From Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine (2020) · cites this paper as [97]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Osteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Pajevic, P. D., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,559
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Méndez‐Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., MacArthur, B. D., Lira, S. A., Scadden, D. T., Ma’ayan, A., Enikolopov, G., & Frenette, P. S. (2010) · Nature · doi:10.1038/nature09262 · Cited by 3,381
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Identification of the haematopoietic stem cell niche and control of the niche size
Zhang, J., Niu, C. S., Ye, L., Huang, H., He, X. C., Tong, W.-G., Ross, J., Haug, J., Johnson, T. J., Feng, J. Q., et al. (2003) · Nature · doi:10.1038/nature02041 · Cited by 2,948
Self-citationA Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature reviews. Immunology · doi:10.1038/nri1779 · Cited by 1,420
Arteriolar niches maintain haematopoietic stem cell quiescence
Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J. U., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., et al. (2013) · Nature · doi:10.1038/nature12612 · Cited by 1,290
Ishikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1350 · Cited by 1,025
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–198 of 198
Wang, W., Bochtler, T., Wuchter, P., Manta, L., He, H., Eckstein, V., Ho, A. D., & Lutz, C. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12934 · Cited by 16
Ruiz-Aparicio, P. F., & Vernot, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050716 · Cited by 17
Li, Q., Nikolova, M. T., Zhang, G., Červenka, I., Valigi, F., Bürri, D., Plantier, E., Mazzoleni, A., Lamouline, A., Schwaller, J., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.009 · Cited by 16
Vernot, J., Bonilla, X., Rodríguez-Pardo, V. M., & Vanegas, N.-D. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020199 · Cited by 15
Pizzo, R. J., Azadniv, M., Guo, N., Acklin, J. A., Lacagnina, K., Coppage, M. L., & Liesveld, J. L. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.01.008 · Cited by 14
Yuan, N., Wei, W., Li, J., Qian, J., Jin, Z., Liu, H., Li, X., Li, L., Zhao, C. N., Gao, X., et al. (2023) · Aging Cell · doi:10.1111/acel.13889 · Cited by 13
Self-citationBCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
Slone, W. L., Moses, B. S., Hare, I., Evans, R., Piktel, D., & Gibson, L. F. (2016) · Oncotarget · doi:10.18632/oncotarget.8273 · Cited by 14
Ramdas, B., Mali, R. S., Palam, L. R., Pandey, R., Cai, Z., Pasupuleti, S. K., Burns, S. S., & Kapur, R. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.002 · Cited by 14
Teng, J.-Y., Yang, D., Tang, C. S., Fang, H., Sun, H., Xiang, Y.-N., Li, X., Yang, F., Xia, R., Fan, F., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01902-3 · Cited by 13
Self-citationTargeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?
Damele, L., Ottonello, S., Mingari, M. C., Pietra, G., & Vitale, C. (2020) · Cancers · doi:10.3390/cancers12040774 · Cited by 13
Distinct and targetable role of calcium-sensing receptor in leukaemia
Pereira, R. S., Kumar, R., Cais, A., Paulini, L., Kahler, A., Bravo, J., Minciacchi, V. R., Krack, T., Kowarz, E., Zanetti, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41770-0 · Cited by 13
Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells
Wang, J., Wang, P., Zhang, T., Gao, Z., Wang, J., Feng, M., Yin, R. L., & Zhang, H. (2019) · Blood Science · doi:10.1097/bs9.0000000000000020 · Cited by 15
Recent progress on targeting leukemia stem cells
Ma, X., Wei, L., Lei, Z., Chen, Y., Ding, Z., & Chen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.009 · Cited by 13
Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment
Blanco, M. N. F., Kazybay, B., Belderbos, M. E., Heidenreich, O. T., & Vormoor, J. H. (2025) · Leukemia · doi:10.1038/s41375-025-02734-z · Cited by 12
Nair, R. R., Piktel, D., Geldenhuys, W. J., & Gibson, L. F. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.08.002 · Cited by 12
Külp, M., Siemund, A. L., Larghero, P., Dietz, A., Alten, J., Cario, G., Eckert, C., Caye‐Eude, A., Cavé, H., Bardini, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104613 · Cited by 11
B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
Barz, M. J., Behrmann, L., Capron, D., Zuchtriegel, G., Steffen, F. D., Kunz, L., Zhang, Y., Vermeerbergen, I. J., Marovca, B., Kirschmann, M., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280451 · Cited by 10
Dormancy Stems the Tide of Chemotherapy
Pal, D., Heidenreich, O. T., & Vormoor, J. H. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.014 · Cited by 11
Smeets, M. W. E., Steeghs, E. M. P., Orsel, J., Stalpers, F., Vermeeren, M. M. P., Veltman, C. H. J., Slenders, L., Nierkens, S., van de Ven, C., & den Boer, M. L. (2024) · Haematologica · doi:10.3324/haematol.2023.283494 · Cited by 10
The evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 10
Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin
Liu, T.-H., Tang, Y.-J., Huang, Y., Wang, L., Guo, X.-L., Mi, J. Q., Liu, L.-G., Zhu, H., Zhang, Y., Chen, L., et al. (2016) · Leukemia · doi:10.1038/leu.2016.313 · Cited by 10
Self-citationBürgler, S., & Nadal, D. (2017) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-017-0072-z · Cited by 10
Garcia-Gimenez, A., & Richardson, S. E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150612 · Cited by 9
Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
Roshandel, E., Tavakoli, F., Parkhideh, S., Akhlaghi, S. S., Ardakani, M. T., & Soleimani, M. (2022) · Health Science Reports · doi:10.1002/hsr2.536 · Cited by 9
High expression of connective tissue growth factor accelerates dissemination of leukaemia
Wells, J. E., Howlett, M., Halse, H. M., Heng, J., Ford, J., Cheung, L. C., Samuels, A. L., Crook, M. L., CHARLES, A. K., Cole, C., et al. (2016) · Oncogene · doi:10.1038/onc.2015.525 · Cited by 9
Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
Li, Z., Shuiping, L., Li, R., Zhu, H., Liu, X., Guo, X., Mu, L., Cai, J.-J., Bai, F., Chen, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0600-3 · Cited by 9
Self-citationJia, R., Sun, T., Zhao, X., Li, G., Xia, Y., Zhou, Y. Y., Li, W., Li, W. S., Ma, D., Ye, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202205854 · Cited by 8
Hematopoietic Stem Cells and Their Bone Marrow Niches
Pinho, S., & Zhao, M. L. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_2 · Cited by 9
FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML
Zhang, J., Qi, L., Wang, T., An, J., Zhou, B., Fang, Y., Liu, Y., Shan, M., Hong, D., Wu, D., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.890346 · Cited by 8
Self-citationCancer-associated fibroblasts in acute leukemia
Gu, L., Liao, P. H., & Liu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022979 · Cited by 8
Li, Y., & Gu, L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01870-7 · Cited by 8
Ruiz-Aparicio, P. F., Uribe, G. I., Ballesteros, A. L., & Vernot, J. (2021) · Molecules · doi:10.3390/molecules26175366 · Cited by 8
Ghamlouch, H., Gagler, D. C., Blaney, P., Boyle, E. M., Wang, Y., Avigan, J. I., Choi, J., Landgren, O., Tsirigos, A., Maura, F., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00606-x · Cited by 7
Li, M., Wang, X., He, W., & Zhou, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1586552 · Cited by 8
Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies
Pan, C., Zheng, L., & Wang, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1596947 · Cited by 7
Zhang, H., Liu, J., Sun, Y., Huang, J., Qi, H., Shao, R., Wu, Q., Jiang, Q., Fu, R., Liu, Q., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200558 · Cited by 7
Zhou, L., Shan, Z., & Fan, J. (2022) · Acta Haematologica · doi:10.1159/000527456 · Cited by 7
Quartin, E., Rosa, S. C., González-Antón, S., Mosteo, L., Francisco, V., Duarte, D., Celso, C. L., das Neves, R. P., & Ferreira, L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.12.017 · Cited by 7
Jiang, Z., Wu, D., Ye, W., Weng, J., Lai, P., Shi, P., Guo, X., Huang, G., Deng, Q., Tang, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22466 · Cited by 6
Jeremias, I., & Schewe, D. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-97746-1_8 · Cited by 6
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic Leukemia
Kegyes, D., Thiagarajan, P. S., & Ghiaur, G. (2024) · Cancers · doi:10.3390/cancers16183208 · Cited by 5
Towards deciphering the bone marrow microenvironment with spatial multi-omics
Yip, R. K. H., Hawkins, E. D., Bowden, R. J., & Rogers, K. L. (2025) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2025.01.001 · Cited by 5
Traxel, S., Schadt, L., Eyer, T., Mordasini, V., Gysin, C., Munthe, L. A., Niggli, F. K., Nadal, D., & Bürgler, S. (2018) · Oncogene · doi:10.1038/s41388-018-0594-4 · Cited by 5
Aref, S., Fawzy, E., Darwish, A., Aref, M. I., & Agdar, M. A. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002010 · Cited by 5
Wilson, A. C., Hockney, S., Parker, J., Angel, S., Blair, H., & Pal, D. (2022) · F1000Research · doi:10.12688/f1000research.123084.1 · Cited by 4
Khanmiri, J. M., Khani-Eshratabadi, M., Seyedmoharrami, F., Khazaee‐Nasirabadi, M. H., Dehdashti, M., Seddighi, N., Peymaninezhad, F., Khiabani, A., Khanahmad, A., & Baradaran, B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02056-z · Cited by 5
Wilson, A. C., Hockney, S., Parker, J., Angel, S., Blair, H., & Pal, D. (2023) · F1000Research · doi:10.12688/f1000research.123084.2 · Cited by 3
Rudzińska, M., Turos-Korgul, L., Mukherjee, D., Podszywalow‐Bartnicka, P., Piwocka, K., & Guzowski, J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad998d · Cited by 6
Shi, P., Lin, Z., Song, Y., Li, Z., Zeng, M., Luo, L., Cao, Y., & Zhu, X. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05692-8 · Cited by 3
Self-citationBone Marrow Stromal Niche: A New Master Regulator of Hematological Myeloid Malignancies
Vgenopoulou, P., & Kousteni, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11257-7 · Cited by 3
Abazarikia, A., Luan, Y., So, W., Becker, M. E., Panda, S., Swenson, S. A., Kosmacek, E. A., Oberley‐Deegan, R. E., Xiao, S., Hyde, R. K., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf022 · Cited by 2
Gu, H., Weng, L., Chen, C., Hao, X., Tao, R., Qi, X., Lai, X., Liu, L., Zhang, T., Jiang, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189051 · Cited by 2
Self-citationClonal evolution in leukemia: preleukemia, evolutionary models, and clinical implications
He, X., Xia, M.-F., Teng, J.-Y., Zhou, B. S., & Wang, Q. (2023) · Genome Instability & Disease · doi:10.1007/s42764-023-00104-6 · Cited by 3
Translating molecular insights into clinical success: alkaloid-based therapies for leukemia
Goleij, P., Tabari, M. A. K., Rezaee, A., Sanaye, P. M., Daglia, M., Alijanzadeh, D., Alsharif, K. F., Kumar, A. P., & Khan, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03540-7 · Cited by 2
Sivagnanalingam, U., Balys, M. M., Eberhardt, A., Wang, N., Myers, J. R., Ashton, J. M., Becker, M. W., Calvi, L. M., & Mendler, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132375 · Cited by 3
Patient-Derived Tumor Xenografts in Hematologic Disorders
Pizzi, M., & Inghirami, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804010-2.00022-9 · Cited by 2
Relapsed Acute Lymphoblastic Leukemia of Childhood
Lum, S. H., Bonney, D. K., & Saha, V. (2017) · Springer eBooks · doi:10.1007/978-3-319-39708-5_11 · Cited by 2
Cancer research driven by cutting-edge multi-disciplinary technologies
Lyu, Q., Feng, Y., Shi, R., Wu, J., & Han, W. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0638 · Cited by 2
Rudzińska, M., Turos-Korgul, L., Mukherjee, D., Podszywalow‐Bartnicka, P., Piwocka, K., & Guzowski, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.10.575000 · Cited by 2
Leukemia cell mobilization: a road to eradication?
Copelan, E. A. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.78 · Cited by 1
Advances in the application of patient-derived xenograft models in acute leukemia resistance
Qin, R.-H., Liang, Y.-X., & Zhou, F.-L. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.18 · Cited by 6
Cortés, S. Á., Paula‐Manuela, R. Z., & Vernot, J. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70009 · Cited by 1
Zhu, J.-M., Xia, J., Chen, K.-M., Bai, X., & Duan, C. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106239 · Cited by 1
Self-citationSun, Y., & Chiao, P. J. (2017) · InTech eBooks · doi:10.5772/66575 · Cited by 1
Baldo, F., Simeone, R., Marcuzzi, A., Grasso, A. G., VIDIMARI, R., Ciriello, F., Zanon, D., Maestro, A., Barbi, E., & Maximova, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173834 · Cited by 1
Seton-Rogers, S. E. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3788 · Cited by 1
Neoplasms in the bone marrow niches: disturbance of the microecosystem
Mu, L., Ke, F., Guo, X., Cai, J.-J., & Hong, D. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2193-5 · Cited by 1
Self-citationA Forecast of Targeting Leukemia Stem Cells by Nanomedicine
Huang, X., Kang, X., & Zhao, M. L. (2017) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000385 · Cited by 1
Lu, C., & Wei, J. (2022) · BioMed Research International · doi:10.1155/2022/1706585 · Cited by 1
RetractedThe Hematopoietic Niche and Bone
Kousteni, S., Frisch, B. J., Galán-Díez, M., & Calvi, L. M. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch125 · Cited by 1
Hou, R., Yang, W., Zhang, Y., Chen, X., Ren, F., Xu, J., Tan, Y., Xu, Z., Chang, J., & Wang, H. (2020) · doi:10.21203/rs.3.rs-16127/v1 · Cited by 1
Tunnelling nanotubules are druggable mediators of cancer-niche crosstalkPreprint
Hockney, S., Parker, J., Tzivelekis, B., Blair, H., Dalgarno, K. W., & Pal, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545732 · Cited by 1
Wang, C., Wang, Y., Benetti, C., Lin, X. X., Dasdemir, E., Hyroššová, P., Tan, J. Y. M., Ayoub, E., Bhatia, K. S., Lim, F. Q., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.01.686055 · Cited by 1
Yao, L., Ruan, C., & Chen, Z. (2015) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2015.02.020
Defining the Mode of Medulloblastoma Growth using the Ptch1 Heterozygous Mouse Model
Vanner, R. J. (2015) · TSpace (University of Toronto)
The role of miRNAs in niche regulation of ALL phenotype
Moses, B. S. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6270
A vérképzőőssejt-niche szerepe a hematológiai neopláziák iniciációjában és progressziójában
Matula, Z., Mikala, G., Urbán, S. V., Valyi-Nagy, I. T., & Uher, F. (2018) · Hematológia–Transzfuziológia · doi:10.1556/2068.2018.51.3.3
Manousopoulou, A., & Wang, L. D. (2020) · British Journal of Haematology · doi:10.1111/bjh.16368
The Role of Bone Stem Cell Niches in Bone Metastasis
Tamma, R., Annese, T., & Ribatti, D. (2020) · Applied Sciences · doi:10.3390/app10217713
Acute lymphoblastic leukemia and the bone marrow microenvironment
Pritchard, C., Heazlewood, S. Y., & Cao, B. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.11.001
Dependence of Acute Myeloid Leukemia Development on Membrane Protein Dipeptidyl Peptidase 4Preprint
Wang, C., Nistala, R., Cao, M., Behrens, M., Doll, D. C., Hammer, R., Nistala, P., Chang, H., Yeh, E. T. H., & Kang, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4052011
Méndez‐Ferrer, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734857233.793575320
Shi, P., Lin, Z., Song, Y., Li, Z., Zeng, M., Luo, L., Cao, Y., & Zhu, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1632846/v1
Self-citationThe role of calcium ions in the leukemic bone marrow microenvironment
Pereira, R. S. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.68681
EGR-mediated relapse mechanisms in infant t(4;11) acute lymphoblastic leukemia
Külp, M. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.70736
Delay tumor progression with the introduction of engineered impactive cellsPreprint
Hong, D., Shuiping, L., Ma, J., Mu, L., Wu, W., Hu, Y., Wang, Y., Guo, X., Cai, J.-J., Wang, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2641539/v1
Self-citationVarious Cell Types in the Bone Marrow sustain Primary B-Cell Precursor Acute Lymphoblastic LeukemiaPreprint
Smeets, M. W. E., van de Ven, C., Orsel, J., Reichert, C. E. J., Boeree, A., Boer, J. M., & den Boer, M. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.25.542080
Fan, H., Xu, Z., Yao, K., Zheng, B., Zhang, Y., Wang, X., Zhang, T., Li, X., Hu, H., Yue, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.15.553338
The expression of CCL-3, FGF2, TPO and CTGF in newly diagnosed acute myeloblastic leukemia (AML)
Farkhondeh, R., Hasanpour, S. Z., Hamidpour, M., Farsani, M. A., Ghasemian, S. O., & Gholami‐Ahangaran, M. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102068
Li, Q., Nikolova, M. T., Zhang, G., Červenka, I., Bürri, D., Plantier, E., Mazzoleni, A., Lamouline, A., Treutlein, B., Martín, I., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5084568
Grockowiak, É. (2017) · theses.fr (ABES) · doi:10.70675/600cdac6za637z42abz900fzf78b400f9638
Wang, H., Liu, L., & Chen, W. (2026) · Nature Protocols · doi:10.1038/s41596-026-01387-1
Rab13 Activates IL-6/STAT3 Pathway for Maintaining Stemness of Breast Tumors
Wang, Z., Zou, L., Jiao, B., Wu, C., & Wang, H. (2026) · Molecular Biology · doi:10.1134/s0026893325605610
Metadata
- Authors
- Duan, C.-W., Shi, J., Chen, J., Wang, B., Yu, Y.-H., Qin, X., Zhou, X.-C., Cai, Y.-J., Li, Z.-Q., Zhang, F., Yin, M.-Z., Tao, Y., Mi, J.-Q., Li, L.-H., Enver, T., Chen, G.-Q., & Hong, D.-L.
- Affiliations
- Shanghai Jiao Tong University (CN)
- University College London (GB)
- Corresponding author
- Enver, Tariq
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 25
- Issue
- 6
- Pages
- 778-793
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2094470615
- Cited by
- 198
- References
- 36
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 9 · 2023: 18 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 13 · 2018: 30 · 2017: 22 · 2016: 16 · 2015: 18 · 2014: 5
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cancer Research UK (12796)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- acute lymphoblastic leukemia, leukemia microenvironment, bone marrow microenvironment, chemoresistance, niche formation, supporting cells, induction therapy, mouse transplantation model
- MeSH terms
- Animals, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone Marrow Cells, Cytarabine, Daunorubicin, Disease Models, Animal, Humans, Neoplastic Stem Cells, Mice, SCID, Mice, Inbred NOD, Xenograft Model Antitumor Assays, Mice, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Stem Cell Niche, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review